Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection

BACKGROUND: The Belgian Superior Health Council (SHC) recently added a 13-valent pneumococcal conjugate vaccine (PCV13) to its recommendations for adult pneumococcal vaccination. This study addresses the policy question regarding whether a single dose of PCV13 should be reimbursed among Belgian adul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Principais autores: Marbaix, Sophie, Peetermans, Willy E., Verhaegen, Jan, Annemans, Lieven, Sato, Reiko, Mignon, Annick, Atwood, Mark, Weycker, Derek
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034794/
https://ncbi.nlm.nih.gov/pubmed/29979689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0199427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados